义大医院E-Da Hospital

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traits. Nature communications, 2026
   • Loss of ST8SIA6 is associated with enhanced MUC16-Integrin β4 signaling and aggressive phenotypes in colorectal cancer. Biochemistry and biophysics reports, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

2. Breast cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Targeting the Extracellular Signal-Regulated Kinase 5-Cellular Jun-Vimentin Axis to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Patients with Triple-Negative Breast Cancer. International journal of medical sciences, 2026
   • CLEC3B (tetranectin) expression is associated with vascular localization and tumor aggressiveness in breast cancer. International journal of medical sciences, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

3. Lung cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Correction to: Response evaluations in non-small cell lung cancer patients undergoing immunotherapy: A comparative analysis of RECIST 1.1, iRECIST, and imRECIST criteria. Medical oncology (Northwood, London, England), 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

4. Liver cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Comparative Effectiveness and Safety of Atezolizumab-Bevacizumab and Durvalumab-Tremelimumab as First-Line Systemic Therapy for Hepatocellular Carcinoma: A Real-World Study. Journal of gastroenterology and hepatology, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

5. Stomach cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Proteomic and Metabolomic Profiling Reveal Mitochondrial Transplantation-Mediated Reprogramming in Gastric Cancer Cells. The Kaohsiung journal of medical sciences, 2026
   • Serum and tissue IGFBP2 as a prognostic biomarker in gastric adenocarcinoma: A multi-cohort clinical validation study. Journal of the Formosan Medical Association = Taiwan yi zhi, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

6. Prostate cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Germline Variation in Notch Pathway and Survival After Androgen Deprivation Therapy in Prostate Cancer: Implicating YAP1 rs1894116 and Focal Adhesion Signaling. Cancer genomics & proteomics, 2026
   • Exploring Genetic Contributions to Prostate Cancer Risk in an Asian Population-Based Study. Cancer medicine, 2026

   另有 2 项已发表研究

   PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。

7. Thyroid cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Long-term risk of incident thyroid cancer after COVID-19 in patients with thyroid disorder: a multicenter propensity score-matched cohort study. Frontiers in endocrinology, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

8. Nasopharyngeal carcinoma

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Prognostic impact of invasion patterns and circumferential spread of internal carotid artery on survival in patients with nasopharyngeal carcinoma. European annals of otorhinolaryngology, head and neck diseases, 2026
   • High-Recall Biomedical Language Models for Radiation Oncology Evidence Synthesis: An Integrated Systematic Review of Prediction Models for Radiotherapy-Induced Complications in Nasopharyngeal Carcinoma. Life (Basel, Switzerland), 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

9. Esophageal cancer

   Taiwan, China 中国台湾 · 获 JCI 认证 (Academic Medical Center Hospital Program)

   已发表研究

   • Integrating genetic and lifestyle determinants in a risk prediction model for esophageal squamous cell carcinoma in Taiwan. Scientific reports, 2026
   • Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling. Anticancer research, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。